| |
NewswireToday - /newswire/ -
Wayne, PA, United States, 10/24/2008 - Sun Biomedical to participate in MEDICA 2008, world's largest international medical trade fair, where OraLine8“ will be featured. OraLine8 is a one-step, on-site, saliva drug screen. This will be the only 8-test product on the market today.
|
| |
Sun Biomedical Laboratories Inc. (SBL) CEO Jack Kerins will be participating in MEDICA, the world’s largest medical fair, in Düsseldorf, Germany on November 19-22, 2008, as part of the Corporate Executive Office (CEO) program of the U.S. Commerce Department. Kerins’ participation is a strategic move to capture a large and flourishing European market for state-of-the-art drug of abuse testing devices. SBL is currently exporting its OraLine“ Saliva Drug Screen to Europe, Australia, and Asia. At the show, SBL will be showcasing its advanced OraLine8“ Saliva Drug Screen, which will include testing for an additional four drugs in a dual testing strip. This will be the only 8-test product on the market today.
The Corporate Executive Office (CEO) at MEDICA program offers U.S. participating firms an opportunity to pursue business internationally. The program has been successfully running for thirteen years as an effective market entry tool for U.S. companies to capture German and other European customers.
MEDICA is the leading international trade fair for medical technology and production. Over 135,000 visitors around the globe and over 4,400 exhibitors from the medical trade are expected to attend.
Sun Biomedical’s OraLine8 Saliva Drug Screen is an extremely accurate immunoassay designed to detect the presence of several illicit drugs in human saliva at levels equal to or greater than the cut-off level indicated. Drugs detected include: marijuana, opiates, cocaine, methamphetamines, barbiturates, benzodiazepine, amphetamine, phencyclidine, ketamine and methadone.
About Sun Biomedical Laboratories, Inc.
Sun Biomedical Laboratories, Inc. (sunbiomed.com) produces both urine and saliva based drugs of abuse testing devices at its main facility in Blackwood, New Jersey. The company has established an industry benchmark with the most sensitive saliva drugs of abuse testing device available on the market today. The company also has a portfolio of research into the use of saliva as a diagnostic medium for other disease states that provide the foundation for continued research and development and a broader portfolio of point of care testing devices. The Company, founded in 1993, is an operating unit of Sun Biomedical Limited, a public company listed on the Australian Stock Exchange (ASX) under the symbol "SBN". For more information about Sun Biomedical Laboratories and its products, contact us at 888-440-8388.
|
fcarb[.]markitects.com 
